Companies / Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc.

Nasdaq: GYRECIK 1124105SAN DIEGO, CA
Insider flow · last 90 daysNet sells $675.2K

Financials · FY2025

Revenue$116.59M
Net income$9.88M
Total debt$0
Cash$43.29M
Diluted EPS$0.02
Shares outstanding111.5M

Ownership

111.5M shares outstanding · as of Aug 1, 2026
0.63%Insiders
Ownership
Insiders0.63%700,000
Institutions3.29%3,670,943
Public float96.08%107,138,906

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
Ying LuoCEOFormerChief Executive Officer · Director
2.30%2,565,226
Ye WeiguoChief Operating Officer
0.63%700,000
Bergmann Joshua BenjaminFormerGC and Corporate Secretary
Chen RuoyuChief Financial Officer
Eastling Thomas WilsonChief Financial Officer
GNI USA, Inc.10% owner
GNI USA, Inc.10% owner

Institutional holders 47

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 4, 2026Ye Weiguo
Executive
SellCommon Stock$120.0K-20K
-2.72%
700,000
0.63% of shares
medium
May 14, 2026Ye Weiguo
Executive
SellCommon Stock$107.7K-16K
-2.18%
700,000
0.63% of shares
medium
Jun 5, 2026Ye Weiguo
Executive
SellCommon Stock$98.6K-15K
-2.15%
700,000
0.63% of shares
low
Jun 9, 2026Ye Weiguo
Executive
SellCommon Stock$89.0K-15K
-2.03%
700,000
0.63% of shares
low
May 15, 2026Ye Weiguo
Executive
SellCommon Stock$87.1K-13K
-1.84%
700,000
0.63% of shares
low
May 6, 2026Ying Luo
CEO
SellCommon Stock$81.5K-10K
-0.39%
2,565,226
2.30% of shares
low
May 21, 2026Ye Weiguo
Executive
SellCommon Stock$78.8K-13K
-1.80%
700,000
0.63% of shares
low
May 19, 2026Ye Weiguo
Executive
SellCommon Stock$58.1K-9K
-1.29%
700,000
0.63% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
GYRECommon StockEquity403783103BBG000F88SY8